SubsAtlas
High-risk education Compare

MDMA vs Ketamine

Educational comparison of reported profiles, risk context, evidence quality and interaction concerns.

Educational context

This comparison covers reported effects, risk profiles, evidence quality and interaction concerns. It is not a recommendation, use guide or ranking.

MDMA compound visual — founder-provided scientific education visual
High-risk education
Founder-provided scientific education visual. Educational context only. Not a use guide. Source and license pending review.
High-risk educationElevated riskModerate evidenceHigh-risk education

MDMA

MDMA is a controlled substance in most countries. Regulated clinical research programs exist in some jurisdictions. Non-medical possession and use is illegal in most regions. This profile is for educational context only.

Ketamine pharmaceutical vial and forms — founder-provided scientific education visual
High-risk education
Founder-provided scientific education visual. Educational context only. Not a use guide. Source and license pending review.
High-risk educationElevated riskModerate evidenceHigh-risk education

Ketamine

Legal status varies by region. This profile is for educational context only.

Images are educational visuals. Plant and fungi visuals are not identification guidance.

Education profile

High-risk comparison

This comparison includes high-risk profiles. Use this information for risk awareness and educational context only.

SubsAtlas does not rank substances as better, safer or more suitable.

Compared profiles

Educational profiles for MDMA and Ketamine.

MDMA compound visual — founder-provided scientific education visual
High-risk education
Founder-provided scientific education visual. Educational context only. Not a use guide. Source and license pending review.
High-risk educationElevated riskModerate evidenceHigh-risk education

MDMA

High-risk education profile focused on overheating, cardiovascular, mood and interaction concerns.

Key caution

Adulteration risk — substances sold as MDMA frequently contain other compounds including fentanyl

Full profile
Ketamine pharmaceutical vial and forms — founder-provided scientific education visual
High-risk education
Founder-provided scientific education visual. Educational context only. Not a use guide. Source and license pending review.
High-risk educationElevated riskModerate evidenceHigh-risk education

Ketamine

High-risk education profile focused on dissociation, impairment, bladder concerns and depressant interactions.

Key caution

Dissociation and impairment risk

Full profile

Comparison matrix

Side-by-side educational context. Not a recommendation or ranking.

Dimension
MDMA compound visual — founder-provided scientific education visual
High-risk education

MDMA

High-risk education
Ketamine pharmaceutical vial and forms — founder-provided scientific education visual
High-risk education

Ketamine

High-risk education
Category
High-risk education
High-risk education
Reported profile
Stimulation and increased energy, Emotional openness — subjective and variable, Elevated heart rate and body temperature, Post-use low mood and fatigue, Sleep disruption
Dissociation, Impairment, Altered perception, Sedation reports
Risk level
Elevated risk
Elevated risk
Evidence quality
Moderate evidence
Moderate evidence
Main cautions
Adulteration risk — substances sold as MDMA frequently contain other compounds including fentanyl; Hyperthermia (overheating) is a documented cause of serious harm and death; Cardiovascular strain — elevated heart rate and blood pressure; Post-use mood disruption — low mood and fatigue commonly reported in following days; Serotonin syndrome risk with MAOIs — a serious and potentially fatal interaction
Dissociation and impairment risk; Accident and injury concern; Bladder and urinary tract concerns with repeated exposure; Interaction risk with depressants
Interaction concerns
Combining MDMA with MAOIs carries serotonin syndrome risk — a potentially fatal interaction. Combining with other serotonergic substances (SSRIs, lithium, tramadol) increases this risk. Combining with stimulants compounds cardiovascular strain. Adulteration of illicit supply is a major unknown risk factor that affects all combination assessments.
Combining with alcohol, GHB, opioids or sedatives may increase risk and is not recommended.
Duration range
Varies by context
Varies by context
Community Signal
Community Signal requires moderated structured reports.
Community Signal requires moderated structured reports.
Legal context
Restricted / controlled
Legal context varies

AI Context

Educational comparison summary from curated archive data. Not a ranking or recommendation.

AI ContextPreviewComparison

MDMA and Ketamine: comparison overview

This is an educational comparison summary of MDMA and Ketamine, not a ranking or recommendation. MDMA has a elevated risk profile with moderate evidence quality. Ketamine has a elevated risk profile with moderate evidence quality. SubsAtlas does not rank substances as better, more suitable or preferable.

  • MDMA: Elevated risk, Moderate evidence.
  • Ketamine: Elevated risk, Moderate evidence.
  • MDMA category: High-risk education.
  • Ketamine category: High-risk education.
  • Legal context — MDMA: controlled.
  • Legal context — Ketamine: varies by region.

This comparison includes high-risk education profiles. AI Context does not provide use or combination guidance.

Related

MDMA profileKetamine profileCompare all profiles

Limitations

  • This is an educational comparison, not a ranking or recommendation.
  • Neither substance is described as better, safer or more suitable.
  • Based on curated SubsAtlas archive data only.
  • Not medical advice. Not legal advice. Not a use guide.
  • Individual responses vary. Source review is ongoing.
  • Do not rely on this for personal decisions.

AI Context summarizes curated SubsAtlas archive data only. Not medical advice. Not legal advice. Not a use guide. No external AI calls are made.

Key differences

Factual educational distinctions between the two profiles.

MDMA is an empathogen/entactogen that primarily releases and blocks reuptake of serotonin, dopamine and norepinephrine; ketamine is a dissociative anaesthetic that acts as an NMDA receptor antagonist.

MDMA produces reported empathogenic, stimulant and mild psychedelic effects; ketamine produces reported dissociative, anaesthetic and analgesic effects.

Ketamine has established medical applications including anaesthesia and, more recently, treatment-resistant depression (esketamine); MDMA-assisted therapy is in clinical trials.

MDMA carries neurotoxicity risk with repeated exposure at high intensities, particularly to serotonergic systems.

Ketamine carries dependence and bladder toxicity risks with frequent repeated exposure.

Both are controlled substances in most jurisdictions; illicit forms carry product quality risks.

Risk context

MDMA's risk profile includes overheating, hyponatraemia (related to fluid management errors), cardiovascular strain and serotonergic neurotoxicity concerns with repeated exposure. Ketamine's risk profile includes dissociative distress, psychological dependence and significant urinary tract/bladder damage with frequent use. Neither is appropriate to combine with each other or with other serotonergic or CNS-affecting substances without medical oversight. Individual response varies significantly.

Evidence context

Ketamine has a substantial clinical evidence base from anaesthesiology and, more recently, from psychiatric research into treatment-resistant depression. MDMA is in late-stage clinical trials for PTSD treatment, though regulatory approval has not yet been granted in all jurisdictions. Community-reported data for both substances carries uncertainty related to product quality, setting and individual variation.

Interaction concerns

Shown for risk awareness only. SubsAtlas does not describe any combination as safe.

MDMA carries significant interaction risks with MAOIs, SSRIs, other serotonergic substances and stimulants. Serotonin syndrome is a documented serious risk. Ketamine interacts with other CNS depressants and opioids. The combination of MDMA and ketamine has been reported in community settings and carries compound risks that are not characterised as safe by any professional body. This page does not provide combination guidance.

Legal context

Legal status varies by country, state and local regulation. This is educational context only — not legal advice.

MDMA

MDMA is a controlled substance in most countries. Regulated clinical and therapeutic research programs exist in some jurisdictions. Non-medical possession and use is illegal in most regions. This profile is for educational context only.

Ketamine

Legal status varies by region. This profile is for educational context only.

Legal status varies by jurisdiction and changes over time. Verify current local law through official sources. How legal context works

Related safety topics

Educational context pages relevant to this comparison.

Interaction awareness

Serotonergic substances

Some substances affect serotonin systems. Combining serotonergic substances may increase serious risk.

Elevated riskRead
Product quality

Unknown product quality

Unknown contents, contamination, mislabeling and variable potency can increase risk.

High riskRead
Emergency awareness

When to seek emergency help

General emergency awareness — recognizing signs that require immediate contact with emergency services.

High riskRead

Related profiles

Educational profiles with related risk or effect context.

LSD compound visual — founder-provided scientific education visual
High-risk education
Founder-provided scientific education visual. Educational context only. Not a use guide. Source and license pending review.
0 reports
High-risk education
High-risk educationElevated risk

LSD

High-risk education profile focused on perception changes, psychological distress and legal context.

Psychological distress risk

Legal: Legal context varies

Moderate evidence
Cocaine compound visual — founder-provided scientific education visual
High-risk education
Founder-provided scientific education visual. Educational context only. Not a use guide. Source and license pending review.
0 reports
High-risk education
High-risk educationHigh risk

Cocaine

High-risk stimulant profile focused on cardiovascular, mental health, dependence and interaction concerns.

High cardiovascular risk

Legal: Legal context varies

Strong evidence

Full educational profiles

Explore each substance profile for complete effects, risk and evidence context.

MDMA

High-risk education profile focused on overheating, cardiovascular, mood and interaction concerns.

Ketamine

High-risk education profile focused on dissociation, impairment, bladder concerns and depressant interactions.

← Compare another profileExplore the AtlasHow SubsAtlas handles evidence and risk

Educational information only. Not medical advice. Effects, risks and responses vary by individual. SubsAtlas does not provide dosing, sourcing, preparation or optimization guidance.